Combination Latency Reversal With High Dose Disulfiram Plus Vorinostat in HIV-infected Individuals on ART (DIVA): A Single Arm Clinical Trial
Phase of Trial: Phase I/II
Latest Information Update: 11 Oct 2017
At a glance
- Drugs Disulfiram (Primary) ; Vorinostat (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms DIVA
- 06 Oct 2017 Status changed from recruiting to suspended.
- 31 Jul 2017 Status changed from not yet recruiting to recruiting.
- 28 Jun 2017 New trial record